• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族病史在评估乳腺癌和结肠癌风险中的作用。

Contribution of extended family history in assessment of risk for breast and colon cancer.

作者信息

Solomon Benjamin L, Whitman Todd, Wood Marie E

机构信息

University of Vermont Medical Center, 111 Colchester Ave, Burlington, VT, 05401, USA.

Champlain Valley Physicians Hospital, 75 Beekman St, Plattsburgh, NY, 12901, USA.

出版信息

BMC Fam Pract. 2016 Sep 1;17(1):126. doi: 10.1186/s12875-016-0521-0.

DOI:10.1186/s12875-016-0521-0
PMID:27580697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5007707/
Abstract

BACKGROUND

Family history is important for identifying candidates for high risk cancer screening and referral for genetic counseling. We sought to determine the percentage of individuals who would be eligible for high risk cancer screening or genetic referral and testing if family history includes an extended (vs limited) family history.

METHODS

Family histories were obtained from 626 women at UVMMC associated mammography centers from 2001 to 2002. ACS guidelines were used to determine eligibility for high risk breast or colon cancer screening. Eligibility for referral for genetic counseling for hereditary breast and colon cancer was determined using the Referral Screening Tool and Amsterdam II screening criteria, respectively. All family histories were assessed for eligibility by a limited history (first degree relatives only) and extended history (first and second degree relatives).

RESULTS

Four hundred ninety-nine histories were eligible for review. 18/282 (3.6 %) and 62/123 (12 %) individuals met criteria for high risk breast and colon cancer screening, respectively. 13/18 (72 %) in the high risk breast cancer screening group and 12/62 (19 %) in the high risk colon cancer screening group met criteria based upon an extended family history. 9/282 (1.8 %) and 31/123 (6.2 %) individuals met criteria for genetic counseling referral and testing for breast and colon cancer, respectively. 2/9 (22 %) of individuals in the genetic breast cancer screening group and 21/31 (68 %) individuals in the genetic colon cancer screening group met criteria based upon extended family history.

CONCLUSIONS

This is one of the first studies to suggest that first degree family history alone is not adequate for identification of candidates for high risk screening and referral for genetic counseling for hereditary breast and colon cancer syndromes. A larger population is needed to further validate this data.

摘要

背景

家族史对于识别高风险癌症筛查的候选者以及转介进行遗传咨询非常重要。我们试图确定如果家族史包括扩展(相对于有限)家族史,符合高风险癌症筛查或遗传转介及检测条件的个体百分比。

方法

2001年至2002年期间,从UVMMC相关乳腺摄影中心的626名女性中获取家族史。采用美国癌症协会(ACS)指南来确定高风险乳腺癌或结肠癌筛查的资格。分别使用转诊筛查工具和阿姆斯特丹II筛查标准来确定遗传性乳腺癌和结肠癌遗传咨询转诊的资格。所有家族史均通过有限家族史(仅一级亲属)和扩展家族史(一级和二级亲属)评估其资格。

结果

499份家族史符合审查条件。分别有18/282(3.6%)和62/123(12%)的个体符合高风险乳腺癌和结肠癌筛查标准。高风险乳腺癌筛查组中13/18(72%)以及高风险结肠癌筛查组中12/62(19%)的个体基于扩展家族史符合标准。分别有9/282(1.8%)和31/123(6.2%)的个体符合乳腺癌和结肠癌遗传咨询转诊及检测标准。遗传性乳腺癌筛查组中2/9(22%)的个体以及遗传性结肠癌筛查组中21/31(68%)的个体基于扩展家族史符合标准。

结论

这是首批表明仅一级家族史不足以识别遗传性乳腺癌和结肠癌综合征高风险筛查及遗传咨询转诊候选者的研究之一。需要更大规模的人群来进一步验证该数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a528/5007707/cfd0ca3df9fa/12875_2016_521_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a528/5007707/7c040a1d7540/12875_2016_521_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a528/5007707/cfd0ca3df9fa/12875_2016_521_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a528/5007707/7c040a1d7540/12875_2016_521_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a528/5007707/cfd0ca3df9fa/12875_2016_521_Fig2_HTML.jpg

相似文献

1
Contribution of extended family history in assessment of risk for breast and colon cancer.家族病史在评估乳腺癌和结肠癌风险中的作用。
BMC Fam Pract. 2016 Sep 1;17(1):126. doi: 10.1186/s12875-016-0521-0.
2
Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.癌症家族史质量和肿瘤学实践中遗传咨询和检测的转诊:作为美国临床肿瘤学会质量肿瘤学实践倡议的一部分,对质量措施的试点测试。
J Clin Oncol. 2014 Mar 10;32(8):824-9. doi: 10.1200/JCO.2013.51.4661. Epub 2014 Feb 3.
3
Automatic Genetic Risk Assessment Calculation Using Breast Cancer Family History Data from the EHR compared to Self-Report.使用电子健康记录(EHR)中的乳腺癌家族史数据与自我报告相比进行自动遗传风险评估计算。
AMIA Annu Symp Proc. 2018 Dec 5;2018:970-978. eCollection 2018.
4
Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.梳理家族病史:基层医疗环境中林奇综合征(遗传性非息肉病性结直肠癌)的评估——执业护士入门指南
J Am Acad Nurse Pract. 2008 Feb;20(2):76-84. doi: 10.1111/j.1745-7599.2007.00282.x.
5
Cancer risk assessment: quality and impact of the family history interview.癌症风险评估:家族史访谈的质量与影响
Am J Prev Med. 2004 Oct;27(3):239-45. doi: 10.1016/j.amepre.2004.05.003.
6
Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand.在初级保健中实施家族健康史风险分层:指南标准对人群和资源需求的影响。
Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):24-33. doi: 10.1002/ajmg.c.31388. Epub 2014 Mar 10.
7
A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.一份可自行填写的家族病史问卷可提高识别出需要转介至遗传咨询以评估遗传性癌症风险的女性。
Gynecol Oncol. 2012 Jun;125(3):693-8. doi: 10.1016/j.ygyno.2012.03.025. Epub 2012 Mar 21.
8
Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.该患者有癌症家族病史吗?一项关于家族癌症病史准确性的循证分析。
JAMA. 2004 Sep 22;292(12):1480-9. doi: 10.1001/jama.292.12.1480.
9
Evaluation of hereditary risk in a mammography population.乳腺钼靶检查人群中遗传风险的评估。
Clin Breast Cancer. 2005 Apr;6(1):38-44. doi: 10.3816/CBC.2005.n.007.
10
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.

引用本文的文献

1
Structural and Contextual Patterns in Family Health History Knowledge among African American Adults: A Mixed-Methods Social Network Analysis Study.非裔美国成年人家庭健康史知识中的结构与情境模式:一项混合方法的社会网络分析研究
J Soc Struct. 2019 Jan;20(3):96-118. doi: 10.21307/joss-2019-008. Epub 2019 Jul 31.
2
Unawareness of breast cancer family history among African women.非洲女性对乳腺癌家族史的认知不足。
Pan Afr Med J. 2023 Aug 30;45:188. doi: 10.11604/pamj.2023.45.188.21616. eCollection 2023.
3
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth and patient-derived xenografts .

本文引用的文献

1
Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.癌症家族史质量和肿瘤学实践中遗传咨询和检测的转诊:作为美国临床肿瘤学会质量肿瘤学实践倡议的一部分,对质量措施的试点测试。
J Clin Oncol. 2014 Mar 10;32(8):824-9. doi: 10.1200/JCO.2013.51.4661. Epub 2014 Feb 3.
2
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.美国临床肿瘤学会专家声明:肿瘤学医疗服务提供者对癌症家族史的收集与使用
J Clin Oncol. 2014 Mar 10;32(8):833-40. doi: 10.1200/JCO.2013.50.9257. Epub 2014 Feb 3.
3
新型靶向PIM1和FGFR1激酶的双重抑制剂可抑制结直肠癌生长及患者来源的异种移植瘤。
Acta Pharm Sin B. 2022 Nov;12(11):4122-4137. doi: 10.1016/j.apsb.2022.07.005. Epub 2022 Jul 15.
4
Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey.美国人报告家族癌症史的比例表明癌症风险增加:2015 年国家健康访谈调查的估计。
Prev Med. 2022 Jun;159:107062. doi: 10.1016/j.ypmed.2022.107062. Epub 2022 Apr 20.
5
Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.1000 名斯洛文尼亚女性样本中遗传性乳腺癌和卵巢癌风险女性的鉴定:指南比较。
BMC Cancer. 2021 Jun 3;21(1):665. doi: 10.1186/s12885-021-08400-8.
6
Evidenced-Based Screening Strategies for a Positive Family History.基于证据的阳性家族史筛查策略。
Gastrointest Endosc Clin N Am. 2020 Jul;30(3):597-609. doi: 10.1016/j.giec.2020.02.015. Epub 2020 Apr 14.
7
Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study.同胞和半同胞的家族性结直肠癌风险:全国队列研究。
BMJ. 2019 Mar 14;364:l803. doi: 10.1136/bmj.l803.
8
Electronically ascertained extended pedigrees in breast cancer genetic counseling.电子获取乳腺癌遗传咨询中的扩展家系信息。
Fam Cancer. 2019 Apr;18(2):153-160. doi: 10.1007/s10689-018-0105-3.
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Feb 18;160(4):271-81. doi: 10.7326/M13-2747.
4
Association between documented family history of cancer and screening for breast and colorectal cancer.癌症家族史与乳腺癌和结直肠癌筛查的关系。
Prev Med. 2013 Nov;57(5):679-84. doi: 10.1016/j.ypmed.2013.08.031. Epub 2013 Sep 9.
5
Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.药物在降低原发性乳腺癌风险中的应用:美国预防服务工作组的系统评价。
Ann Intern Med. 2013 Apr 16;158(8):604-14. doi: 10.7326/0003-4819-158-8-201304160-00005.
6
Attitudes and practices among internists concerning genetic testing.内科医生对基因检测的态度和做法。
J Genet Couns. 2013 Feb;22(1):90-100. doi: 10.1007/s10897-012-9504-z. Epub 2012 May 15.
7
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.美国国立综合癌症网络(NCCN)肿瘤学临床实践指南:乳腺癌筛查与诊断
J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96. doi: 10.6004/jnccn.2009.0070.
8
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.一份用于基层医疗中遗传性乳腺癌识别的简易问卷的开发与验证
BMC Cancer. 2009 Aug 14;9:283. doi: 10.1186/1471-2407-9-283.
9
Cancer care: a microcosm of the problems facing all of health care.癌症护理:整个医疗保健所面临问题的一个缩影。
Ann Intern Med. 2009 Apr 21;150(8):573-6. doi: 10.7326/0003-4819-150-8-200904210-00024.
10
ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.美国妇产科医师学会实践公报第103号:遗传性乳腺癌和卵巢癌综合征
Obstet Gynecol. 2009 Apr;113(4):957-966. doi: 10.1097/AOG.0b013e3181a106d4.